Z-0367-2016 Class II Terminated

Recalled by Merz North America, Inc. — Raleigh, NC

FDA device recall Z-0367-2016 was initiated by Merz North America, Inc. on Oct 26, 2015 and is designated Class II. Reason for recall: The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect. The recall status is terminated (terminated May 8, 2017). Affected quantity: 7,715 units.

Recall details

Product Type
Devices
Report Date
Dec 9, 2015
Initiation Date
Oct 26, 2015
Termination Date
May 8, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,715 units

Product description

PROLARYN Injectable Implant 1.0 cc Gel, Model No. 8602M0K5. A restorable implant material to aid in surgical reconstructions as a space occupying material in laryngeal surgical procedures for vocal fold medialization and augmentation.

Reason for recall

The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.

Distribution pattern

Distributed US (nationwide) including the Virgin Islands and South Africa.

Code information

Lot Number 100079214, 100077099, 100077251, 100077252, 100077253, 100078692, 100079598, 100080204, 100081409, 100081577, 100082304, 100082438, 100083371, 100083875, 100083932

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-0367-2016
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-0367-2016. Report a data issue: hello@regdatalab.com.